GGrantIndex
Sort

51,570 grants matching autoimmune disease

Small molecules and antibodies interacting at the TSH receptor

$396,201
Terry Francis Davies · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · DK

Small molecules and antibodies interacting at the TSH receptor

$396,201
Terry Francis Davies · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · DK

Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica

$396,200
Michael Levy · Massachusetts General Hospital · R01 · FY2021 · AI

Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica

$396,200
Michael Levy · Massachusetts General Hospital · R01 · FY2020 · AI

Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica

$396,200
Michael Levy · Massachusetts General Hospital · R01 · FY2022 · AI

Dermal Lymphatic Transport and Cutaneous Immune Balance

$396,189
Amanda W. Lund · New York University School Of Medicine · R01 · FY2025 · AR

Identification of human cytomegalovirus life cycle stage-specific therapeutics

$396,177
Domenico Tortorella · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AI

Identification of human cytomegalovirus life cycle stage-specific therapeutics

$396,177
Domenico Tortorella · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AI

Identification of human cytomegalovirus life cycle stage-specific therapeutics

$396,177
Domenico Tortorella · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AI

Function of IL35+ B cells in pancreatic cancer

$396,171
Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2024 · CA

Checkpoints of Host Response to Cellular Injuries

$396,157
Yang Liu · Children'S Research Institute · R01 · FY2013 · AI

Deciphering Post-transcriptional Gene Regulatory Networks During Periods of Host-Pathogen Interaction and Innate Immune Activation

$396,146
Manuel Ascano · Vanderbilt University · R35 · FY2021 · GM

In vivo targeting of hematopoetic cells with glycan ligands of siglecs

$396,086
James C. Paulson · Scripps Research Institute, The · R01 · FY2010 · CA

Beyond PECAM: Mechanisms of Transendothelial Migration

$396,083
William A Muller · Northwestern University At Chicago · R37 · FY2013 · HL

Discovering the Mechanism of Action of a peptide drug, OPT101, that targets CD40 mediated inflammation in type 1 diabetes

$396,060
David H Wagner · University Of Colorado Denver · R01 · FY2025 · DK

Foxp transcription factors in regulatory T cell development and homeostasis

$396,056
Jonathan S Maltzman · University Of Pennsylvania · R56 · FY2014 · AI

Studies of Ocular inflammation: Clinical & Translational Research

$396,008
Rachel R. Caspi · National Eye Institute · ZIA · FY2025 · EY

The coevolutionary dynamics of pleiotropic genetic architecture

$396,004
Ann Thomas Tate · Vanderbilt University · R35 · FY2023 · GM

The coevolutionary dynamics of pleiotropic genetic architecture

$396,004
Ann Thomas Tate · Vanderbilt University · R35 · FY2022 · GM

The coevolutionary dynamics of pleiotropic genetic architecture

$396,004
Ann Thomas Tate · Vanderbilt University · R35 · FY2024 · GM

Novel Mechanisms of Calcium Signaling in B lymphocytes

$396,000
Bruce D Freedman · University Of Pennsylvania · R01 · FY2011 · AI

Novel Mechanisms of Calcium Signaling in B lymphocytes

$396,000
Bruce D Freedman · University Of Pennsylvania · R01 · FY2014 · AI

Regulation of the early immune response to toxoplasma gondii

$396,000
Christopher A Hunter · University Of Pennsylvania · R01 · FY2010 · AI

TWEAK and Skin Inflammation

$396,000
Michael Croft · La Jolla Institute For Immunology · R01 · FY2020 · AR

T helper 2 Inflammation & Severe Muscularization of Arteries in the Lungs.

$396,000
Gabriele Grunig · New York University School Of Medicine · R01 · FY2012 · HL